Department of Neonatology, Shaare Zedek Medical Center, Shmuel Bait Street 12, 913102, Jerusalem, Israel.
Hebrew University of Jerusalem, Jerusalem, Israel.
Curr Nutr Rep. 2022 Jun;11(2):311-317. doi: 10.1007/s13668-022-00411-6. Epub 2022 Mar 26.
To perform a systematic review of prospective clinical trials to determine whether improving vitamin D status improves asthma control.
In cross sectional studies suboptimal viramin D status is often associated with poor asthma control. However, decreased 25-hydroxycholecalciferol (25 (OH) D) concentrations might not be causally associated with asthma control. We performed a systematic review until December 15, 2021 according to PRISMA guideline, searching MEDLINE, MEDLINE In-Process, Embase, Cochrane Database of Systematic Reviews, and Cochrane Central Register of Controlled Trials. Two searches were performed, the first using "vitamin D" and the second using "Vitamin D" or "ergocalciferol" or "cholecalciferol" and "Asthma". From 419 retrieved papers, after removal of duplicate and after using exclusion criteria, 28 full-text articles were eligible, of which 6 remained for quantitative analysis and 11 (9 studies) for qualitative analysis. From both analyses, prospective studies do not support that improving the vitamin D status of asthmatic children improves asthma control.
对前瞻性临床试验进行系统回顾,以确定改善维生素 D 状况是否能改善哮喘控制。
在横断面研究中,维生素 D 状态不佳通常与哮喘控制不佳有关。然而,25-羟胆钙化醇(25(OH)D)浓度降低可能与哮喘控制无关。我们按照 PRISMA 指南进行了系统评价,检索了 MEDLINE、MEDLINE 在处理中、Embase、Cochrane 系统评价数据库和 Cochrane 对照试验中心注册库,截至 2021 年 12 月 15 日。进行了两次搜索,第一次使用“vitamin D”,第二次使用“Vitamin D”或“ergocalciferol”或“cholecalciferol”和“asthma”。从 419 篇检索到的论文中,去除重复项并使用排除标准后,有 28 篇全文文章符合条件,其中 6 篇用于定量分析,11 篇(9 项研究)用于定性分析。这两项分析都表明,前瞻性研究并不支持改善哮喘儿童的维生素 D 状况能改善哮喘控制。